In This Section

Home / Learn / Community Oncology Research

Community Oncology Research

Expanding access to clinical trials is instrumental in achieving equitable cancer care delivery. Clinical trials can be a lifeline for patients with cancer, providing leading-edge care by clinicians dedicated to a specific disease. The oncology community is filled with stories of patients whose lives were improved and/or extended due to participation in a clinical trial. Yet, despite the potential of clinical research to improve outcomes for patients with cancer, enrollment in trials remains low.

The Association of Community Cancer Centers (ACCC) is dedicated to helping the oncology community advance new therapies, expand access to clinical trials, and to close the gap in cancer care delivery by offering the latest education and resources on real-world research, evidence, and clinical trials.

ACCC Community Oncology Research Institute

The ACCC Community Oncology Research Institute (ACORI) was launched to address disparities in cancer research and to establish clinical trials as a standard of care for all cancer patients.

ASCO-ACCC Joint Initiatives

The American Society of Clinical Oncology (ASCO) and ACCC have jointly released the Just ASK™ Training Program and Site Self-Assessment resources to help increase the racial and ethnic equity, diversity, and inclusion in cancer clinical trials.

Expanding Access to Clinical Trials

ACCC is committed to ensuring clinical trials are accessible to underserved populations and to closing the gap in cancer research resulting in equitable representation for all patients.

More Community Oncology Research Resources

From the ACCCBuzz Blog

  • #AMCCBS: Clinical & Operational Updates in Oncology
    March 09, 2023
    Before opening the ACCC 49th Annual Meeting & Cancer Center Business Summit to its membership, ACCC held two pre-conference events on Wednesday, March 8. Learn more about what was discussed among invited speakers during these events.
  • ACCC Announces its 2023 Advocacy Agenda
    March 07, 2023
    For 2023, ACCC members have identified four core areas of focus (e.g., reimbursement, utilization management, provider-patient choice), among a larger set of issues and concerns, that the association will be supporting this year.
  • Precision Medicine: Stories from the CRISPR Revolution
    January 31, 2023
    Dr. Kevin Davies previews his opening keynote at the upcoming Association of Community Cancer Centers (ACCC) 49th Annual Meeting & Cancer Center Business Summit (AMCCBS).

Cancer Buzz Podcasts

  • Cannabis and Cancer: Developing a Patient Clinic — [PODCAST] Ep 86
    Jul 12, 2022
    The demand for medical cannabis education from both providers and patients is increasing dramatically as stigma on its use decreases. Learn how the Cannabis and Cancer Research and Education Clinic (CanCaRE) is helping meet this growing need. 
  • [PODCAST] Ep 84: Increasing Clinical Trial Access for Blood Cancers
    Jun 7, 2022

    Clinical trials are the best instrument to advance treatment for blood cancers, but numerous challenges exist around trial identification, enrollment, and participation. We’ll hear perspectives from a community provider and patient advocacy organization on immediate—and forward-thinking—solutions to help this population better access clinical trials, including a tool from the Leukemia and Lymphoma Society to help patients identify cancer clinical trials that may be a fit.

  • [MINI-PODCAST] Ep 65: Integrating Advanced Practitioners into Research
    Aug 3, 2021
    In this episode, we'll hear the evolution of the advanced practitioners (APs) role at her institution, where APs have a larger voice in the research process and clinical trial protocols, serve as champions to advocate for patients and research staff, and collaborate with their team to promote best practices in clinical trial delivery.

On-Demand Webinars

  • An online implicit bias training program that presents the broader context of structural and systemic racism, the role of implicit bias in clinical trial selection, vignettes with real-world examples of implicit bias, and guidance for mitigating disparities in cancer research settings.

  • The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event that explored practical solutions to strengthen and diversify oncology clinical trials in communities across the country.
    (Sep 13-14, 2021)

  • An expert panel reviews currently available data on cancer care disparities, discusses the needs of disadvantaged populations, and shares practical solutions and methods for implementing bias training. (April 20, 2021)

From Oncology Issues

  • Views: Fertility Preservation for Women with Cancer
    James Grifo, MD, PHD
    Advancements in reproductive science has provided more options for women to take greater control of their reproductive future.
  • Action
    ACCC and AstraZeneca were recognized for their joint effort in the Rural Appalachian Lung Cancer Screening Initiative at the Cancer Moonshot: Goals Forum hosted, by the President and First Lady.
  • Tech Solutions Ahead!
    By David R. Penberthy, MD, MBA
    Technology-drive solutions will be essential in the future of cancer care, and providing the information, education and resources health care providers need to implement those solutions is important.